KR950700539A - 백혈구 상사체에 대한 혈액학적 대조 조성물, 그의 제조방법 및 용도(hematology control composition for leukocyte analogs, and methods for their preparation and use) - Google Patents

백혈구 상사체에 대한 혈액학적 대조 조성물, 그의 제조방법 및 용도(hematology control composition for leukocyte analogs, and methods for their preparation and use)

Info

Publication number
KR950700539A
KR950700539A KR1019940702936A KR19940702936A KR950700539A KR 950700539 A KR950700539 A KR 950700539A KR 1019940702936 A KR1019940702936 A KR 1019940702936A KR 19940702936 A KR19940702936 A KR 19940702936A KR 950700539 A KR950700539 A KR 950700539A
Authority
KR
South Korea
Prior art keywords
analogs
control composition
cell
leukocyte analogs
leukocyte
Prior art date
Application number
KR1019940702936A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR950700539A publication Critical patent/KR950700539A/ko

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2496/00—Reference solutions for assays of biological material
    • G01N2496/05—Reference solutions for assays of biological material containing blood cells or plasma
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666—Particle count or volume standard or control [e.g., platelet count standards, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/102499—Blood gas standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/105831—Protein or peptide standard or control [e.g., hemoglobin, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/106664—Blood serum or blood plasma standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/107497—Preparation composition [e.g., lysing or precipitation, etc.]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331—Preservative, buffer, anticoagulant or diluent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
KR1019940702936A 1992-02-24 1994-08-23 백혈구 상사체에 대한 혈액학적 대조 조성물, 그의 제조방법 및 용도(hematology control composition for leukocyte analogs, and methods for their preparation and use) KR950700539A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84043592A 1992-02-24 1992-02-24
PCT/US1993/001855 WO1993017330A1 (en) 1992-02-24 1993-02-17 Hematology control composition for leukocyte analogs; and methods for their preparation and use

Publications (1)

Publication Number Publication Date
KR950700539A true KR950700539A (ko) 1995-01-16

Family

ID=25282374

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940702936A KR950700539A (ko) 1992-02-24 1994-08-23 백혈구 상사체에 대한 혈액학적 대조 조성물, 그의 제조방법 및 용도(hematology control composition for leukocyte analogs, and methods for their preparation and use)

Country Status (11)

Country Link
US (2) US5320964A (ko)
EP (1) EP0628167B1 (ko)
JP (1) JP3391451B2 (ko)
KR (1) KR950700539A (ko)
AT (1) ATE195810T1 (ko)
AU (1) AU665413B2 (ko)
BR (1) BR9305952A (ko)
CA (1) CA2129832A1 (ko)
DE (1) DE69329274T2 (ko)
NO (1) NO943115L (ko)
WO (1) WO1993017330A1 (ko)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5270208A (en) * 1991-05-09 1993-12-14 Streck Laboratories, Inc. White blood cell hematology control
US6362003B1 (en) * 1992-02-24 2002-03-26 Coulter Corporation Hematological reference control composition containing leukocyte analogs, methods of making, and uses thereof
US6509192B1 (en) * 1992-02-24 2003-01-21 Coulter International Corp. Quality control method
AU665413B2 (en) * 1992-02-24 1996-01-04 Coulter International Corporation Hematology control composition for leukocyte analogs; and methods for their preparation and use
US5891734A (en) * 1994-08-01 1999-04-06 Abbott Laboratories Method for performing automated analysis
US5631165A (en) * 1994-08-01 1997-05-20 Abbott Laboratories Method for performing automated hematology and cytometry analysis
US5656499A (en) * 1994-08-01 1997-08-12 Abbott Laboratories Method for performing automated hematology and cytometry analysis
WO1996012181A1 (en) * 1994-10-12 1996-04-25 Research & Diagnostics Systems, Inc. Reticulocyte assay control
EP0771420A1 (en) * 1995-04-28 1997-05-07 Coulter International Corp. Quality control method of hematology instruments
US5858790A (en) 1996-06-26 1999-01-12 Abbott Laboratories Hematology reference control and method of preparation
US6146901A (en) * 1997-06-16 2000-11-14 Hematronix, Inc. Composition for manipulating optical and electrical properties of particles to achieve target values for such properties and methods for using the composition
US5994139A (en) * 1998-04-07 1999-11-30 Coulter International Corp. Stable hematology control composition and method of use
US6200500B1 (en) 1999-08-20 2001-03-13 Streck Laboratories, Inc. Hematology control and system for multi-parameter hematology measurements
US6221668B1 (en) * 1999-08-20 2001-04-24 Streck Laboratories, Inc. Hematology control and system for multi-parameter hematology measurements
US6444471B1 (en) 1999-10-18 2002-09-03 Research & Diagnostic Systems, Inc. Reticulocyte containing complete blood control
US6653063B2 (en) 2000-06-12 2003-11-25 Hematronix, Inc. Hematology composition using preserved white blood cells in combination with source particles to simulate native white blood cells and method of making same
DE60125549T2 (de) * 2000-06-12 2007-06-28 Bio-Rad Laboratories, Inc., Hercules Hämatologische zusammensetzung mit präservierten weissen blutkörperchen
US6569682B2 (en) * 2001-07-27 2003-05-27 Coulter International Corp. Hematology control product with increased closed vial stability
JP4428628B2 (ja) 2001-10-16 2010-03-10 コード バイオテック リミテッド 修飾細胞から製造される血清学用の感受性対照
US6759246B1 (en) * 2001-11-30 2004-07-06 Research & Diagnostic Systems, Inc. Hematology control composition including lymphocyte analogs and method for preparation and use
US6653137B2 (en) 2001-12-03 2003-11-25 Streck Laboratories Inc. Hematology reference control
US6723563B2 (en) 2001-12-03 2004-04-20 Streck Laboratories Inc. Hematology reference control
EP1422509A1 (en) * 2002-11-01 2004-05-26 Streck Laboratories, Inc. Lysing Reagent and Method of Lysing Red Blood Cells for Hematology
EP1668353B1 (en) * 2003-10-02 2015-03-18 Beckman Coulter, Inc. Reference control for optical measurement of nucleated red blood cells of a blood sample
US7198953B2 (en) * 2003-10-12 2007-04-03 Beckman Coulter, Inc. Method of using a reference control composition for measurement of nucleated red blood cells
US7195919B2 (en) * 2003-12-19 2007-03-27 Beckman Coulter, Inc. Hematology controls for reticulocytes and nucleated red blood cells
US7135341B2 (en) * 2004-04-07 2006-11-14 Beckman Coulter, Inc. Reference control containing a nucleated red blood cell component
US7109036B2 (en) * 2004-05-13 2006-09-19 Beckman Coulter, Inc. Hematology reference control containing an immature granulocyte component
US7354767B2 (en) * 2006-03-16 2008-04-08 Beckman Coulter, Inc. Reference control composition containing a nucleated red blood cell component made of non-nucleated blood cells
EP2082224B1 (en) 2006-11-14 2015-05-13 Beckman Coulter, Inc. Hematology linearity control composition system and method of use
US7618821B2 (en) 2007-04-13 2009-11-17 Streck, Inc. Simulated blood components and methods
CN101311724B (zh) * 2007-05-24 2014-11-12 深圳迈瑞生物医疗电子股份有限公司 单群白细胞模拟离子、包含单群白细胞模拟离子的校准物及其制备方法
CN101311725B (zh) * 2007-05-25 2014-03-26 深圳迈瑞生物医疗电子股份有限公司 一种五分类白细胞质控物及其制备方法
CN101561443B (zh) * 2008-04-15 2013-08-21 深圳迈瑞生物医疗电子股份有限公司 五分类白细胞模拟物粒子、其制备方法以及含该模拟粒子的质控物和校准物
US20100086962A1 (en) 2008-10-08 2010-04-08 Streck, Inc. Hematology controls and methods
CN101887059B (zh) * 2009-05-11 2014-03-19 深圳迈瑞生物医疗电子股份有限公司 嗜酸性粒细胞模拟物、制备方法及全血质控物
CN102109430B (zh) * 2009-12-25 2013-11-06 深圳迈瑞生物医疗电子股份有限公司 有核红细胞模拟粒子，血液质控物及其制备方法和用途
BR112013024985B1 (pt) * 2011-04-28 2022-06-07 Beckman Coulter, Inc Composições de controle de hematologia e método para determinar a precisão operacional e a reprodutibilidade de um instrumento de hematologia
EP3859425B1 (en) 2015-09-17 2024-04-17 S.D. Sight Diagnostics Ltd. Methods and apparatus for detecting an entity in a bodily sample
US11307196B2 (en) 2016-05-11 2022-04-19 S.D. Sight Diagnostics Ltd. Sample carrier for optical measurements
EP3491381A1 (en) 2016-07-29 2019-06-05 Streck, Inc. Suspension composition for hematology analysis control
US11921272B2 (en) 2017-11-14 2024-03-05 S.D. Sight Diagnostics Ltd. Sample carrier for optical measurements
CN111366737A (zh) * 2018-12-26 2020-07-03 深圳市帝迈生物技术有限公司 血细胞分析仪用质控物及其制备方法、血细胞分析仪

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2656508A (en) * 1949-08-27 1953-10-20 Wallace H Coulter Means for counting particles suspended in a fluid
US3502974A (en) * 1966-05-23 1970-03-24 Coulter Electronics Signal modulated apparatus for generating and detecting resistive and reactive changes in a modulated current path for particle classification and analysis
US3741875A (en) * 1970-10-30 1973-06-26 Mount Sinai Res Foundation Inc Process and apparatus for obtaining a differential white blood cell count
BE790042A (nl) * 1971-10-14 1973-04-13 Coulter Electronics Werkwijze voor het classifiseren van deeltjes
US3873467A (en) * 1974-02-01 1975-03-25 United Medical Lab Inc Hematologic reference control
US4219440A (en) * 1979-06-06 1980-08-26 Coulter Electronics, Inc. Multiple analysis hematology reference control reagent and method of making the same
US4358394A (en) * 1979-05-07 1982-11-09 Coulter Electronics, Inc. Process for preparing whole blood reference controls having long term stability
US4299726A (en) * 1979-05-07 1981-11-10 Coulter Electronics, Inc. Process for preparing whole blood reference controls having long term stability, preconditioning diluent and media therefor
US4324686A (en) * 1979-06-11 1982-04-13 R & D Systems, Inc. Hematology control composition and methods for its use
US4436821A (en) * 1982-04-12 1984-03-13 Streck Laboratories, Inc. Simulated human platelets from red blood cells
US4485175A (en) * 1983-01-03 1984-11-27 Coulter Electronics, Inc. Method for three-volume differential determination of lymphocyte, monocyte and granulocyte populations of leukocytes
US4579824A (en) * 1983-05-18 1986-04-01 Louderback Allan Lee Hematology control
US4745074A (en) * 1984-02-23 1988-05-17 Cooper-Lipotech Partnership Blood-fluid composition for cell lysis system
US4704364A (en) * 1984-05-18 1987-11-03 Coulter Electronics, Inc. Hematology control compositions for three populations of leukocytes; and methods for their preparation and use in whole blood control systems
US4751179A (en) * 1984-05-31 1988-06-14 Coulter Electronics, Inc. Method and reagents for differential determination of four populations of leukocytes in blood
US4777139A (en) * 1987-06-25 1988-10-11 Fisher Scientific Company Hematology control or calibrator with red cell components of enhanced stability
US5008201A (en) * 1990-05-24 1991-04-16 Streck Laboratories, Inc. Simulated human platelets from red blood cells
AU665413B2 (en) * 1992-02-24 1996-01-04 Coulter International Corporation Hematology control composition for leukocyte analogs; and methods for their preparation and use

Also Published As

Publication number Publication date
ATE195810T1 (de) 2000-09-15
JPH07504038A (ja) 1995-04-27
DE69329274T2 (de) 2001-04-12
NO943115D0 (no) 1994-08-23
WO1993017330A1 (en) 1993-09-02
DE69329274D1 (de) 2000-09-28
US5320964A (en) 1994-06-14
JP3391451B2 (ja) 2003-03-31
AU3736693A (en) 1993-09-13
EP0628167A1 (en) 1994-12-14
US5512485A (en) 1996-04-30
NO943115L (no) 1994-09-01
EP0628167A4 (en) 1996-10-30
CA2129832A1 (en) 1993-08-25
EP0628167B1 (en) 2000-08-23
AU665413B2 (en) 1996-01-04
BR9305952A (pt) 1997-10-21

Similar Documents

Publication Publication Date Title
KR950700539A (ko) 백혈구 상사체에 대한 혈액학적 대조 조성물, 그의 제조방법 및 용도(hematology control composition for leukocyte analogs, and methods for their preparation and use)
NO943116L (no) Suspensjonsmedia for hematologisk sammensetning og fremgangsmåte for dens anvendelse
AU4352785A (en) Hematology control compositions for three populations of leukocytes; and methods for their preparation and use in whole blood control systems
DE3580973D1 (de) Geraet zur bestrahlung von blutteilen.
DE69117750D1 (de) Vorrichtung zum herstellen von koagulationsfaktorkonzentraten, wie fibrinogen, aus blutproben
DE68916244T2 (de) Blutplättchenlysat, verfahren zu seiner herstellung sowie ein solches lysat enthaltendes zellkulturmedium.
CA2235348A1 (en) Absorbent composite and disposable absorbent garment comprising same
ES291678U (es) Sonda de dialisis principalmente prevista para su insercion en tejidos biologicos
DE3572179D1 (en) Blood coagulation inhibiting proteins, process for preparing them and their use
AU5350290A (en) Factor sensitive reagent for testing of blood coagulation
Lerner et al. Endotoxin induced disseminated intravascular clotting: evidence that it is mediated by neutrophil production of tissue factor
DE69631059D1 (de) Standard zur blutkontrolle
Toder et al. Activity of natural killer cells in normal pregnancy and edema-proteinuria-hypertension gestosis
Kimura et al. Hematopoiesis in the rat: quantitation of hematopoietic progenitors and the response to iron deficiency anemia
WO1987003802A3 (fr) Dispositif et instrument de reception et d'introduction de tissus dans le corps humain
Alter et al. Control of the simian fetal hemoglobin switch at the progenitor cell level
Kaizer et al. Post‐mitotic age of mononuclear cells migrating into Ta‐3 (St) solid tumors
CA2052883A1 (en) Pledget compositions and process for making same
Wilding et al. Use of pattern recognition technology for determination of the human differential leukocyte count
Wikner et al. [20] Chemotactic fragments of fibronectin
Krantz et al. Purification of erythroid progenitor cells and characterization of erythropoietin receptors.
SU826248A1 (ru) СПОСОБ ОПРЕДЕЛЕНИЯ ПОТКНЦИАЛЬНОЯ ГИПЕРАКТИВНОСТИ CИCTE^Щ СВЕРТЫВАНИЯ КРОВН1Изобретение относитс к области медицины и может найти применение в диагностике массивных тромбозов, тромбоэмболии и диссеминированного в-нутрисосудистого свертывани кро- 5 аи, осложн ющего токсикозы беременных, эмболии околоплодными водами, пре>&вдевременной отслойки плаценты, задержки мертвого плода в матке, шоков любой этиологии, инфекционных 10 3 аболеваний.. и др.Известно, что. при развившемс остром массивном тромбозе, массивной тромбоэмболии и остром диссе- минированном внутрисосудистом свер- 15 тьшании крови, в св зи с "потреблением" р да плазменных факторов свертывани крови и тромбоцитов, а также в СВЯЗИ':с вторичной активацией' системы фибринолиза в периферйчес- 20 кой крови отмечаетс .гипокоагул ци . Важное отличие этой, гипокоагул ции от гипокоагул ции, св зешных с недостаточным образованием плазменных факторов свертывани или тромбоцитов^ 25 заключаетсй в том, что оно сочетаетс с присутствием в кровотоке активаторов свертывани крови.Известен способ вы влени потенциальной гиперактивности системы све» 30ртывани крюви, заключающийс в том, что берут плазму здорового и смесь равных объемов плазм здорового и больного, помещают их последовательно в тромбоэластограф,добавл ют раствор СаСЕг и записывают тромбоэластограммы. При наличии потенциальной гиперкоагул ции соотношение R смеси/R здорового >& 1 [1], • Недостатком способа вл етс то, что он вы вл ет потенциальную активацию только плазменного звена гемостаза, тогда как инициаци процессов гемостаза может осуществл тьс и через тромбоцитарное звено. Кроме того, способ не дает ответа на вопрос, показано ли больному назначение антиагрегатов (ингибиторов агрегации тромбоцитов).Цель изобретени - повышение точности способа.Поставленна цель достигаетс тем, что в способе определени потенциальной гиперактивности системы свертывани крови путем исследовани свертываемости плазмы здорового человека и смеси равных объемов плазмы здорового и больного, к испытуемым образцам тромбоцитной плазмы добавл ют стимул торы агрегации тромбоцитов.
Wildevuur-van Hamersveld et al. Hematologic abnormalities in extracorporeal circuits (ECC)
Favrot et al. Correspondence re: John R. Yanelli et al., Enhancement of Human Lymphokine-activated Killer Cell Cytolysis and a Method for Increasing Lymphokine-activated Killer Cell Yields to Cancer Patients. Cancer Res., 48: 5696-5700, 1988
Sprinz Benninghoff's Makroskopische und Mikroskopische Anatomie des Menschen

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application